Skip to content

Targeted Evaluation, Action, & Monitoring of Traumatic Brain Injury

Targeted Evaluation, Action, & Monitoring of Traumatic Brain Injury

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02657135
Acronym
TEAM-TBI
Enrollment
95
Registered
2016-01-15
Start date
2014-03-24
Completion date
2018-03-23
Last updated
2018-07-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Traumatic Brain Injury (TBI)

Brief summary

TEAM-TBI (Targeted Evaluation, Action, and Monitoring of Traumatic Brain Injury) is a research study that brings together TBI patients, advanced evaluation methods, and experts in a multi-faceted study to address the heterogeneity of TBI and to evaluate the effects self-help strategies might have on TBI outcomes.

Detailed description

TEAM-TBI (Targeted Evaluation, Action, and Monitoring of Traumatic Brain Injury) proposes a new approach to clinical trials in TBI that will: * Evolve diagnostic technology & treatment * Improve self-help strategies * Lower cost and speed for delivery of effective strategies The TEAM-TBI program proposes an innovative new approach to TBI clinical trials to overcome the limitations of past efforts and achieve long-awaited breakthroughs for TBI survivors. The study will involve a comprehensive 3-4 day intake evaluation, followed by a variety of remotely performed tasks during a 1-6 month follow-up period.

Interventions

These tests will be used to determine how the participant will continue with future procedures, and depending on results, may involve the participant returning to complete subsequent testing.

These assessments will involve a series of tests and questionnaires that focus on physical symptoms of TBI and will include dizziness, balance, ocular-motor coordination, and reflexes.

OTHERCervical (Neck) Evaluation

These assessments will involve a series of tests and questionnaires that focus on physical symptoms of TBI including neck mobility and pain levels.

These evaluations will focus on assessing insomnia (duration, frequency, daytime consequences), combat exposure, and the presence and severity of trauma history.

OTHERHDFT MRI

This MRI aims at providing qualitative and quantitative assessments of the nature, location, and extent of white matter injury.

This is a noninvasive diagnostic test for measuring biochemical changes in the brain.

This is a non-invasive neurophysiological technique that measures the magnetic fields generated by neuronal activity of the brain.

Sponsors

United States Department of Defense
CollaboratorFED
University of Pittsburgh
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* 18-60 years of age * Fluent in English * Documented history of TBI or blast exposure since 2001

Exclusion criteria

* Inability to have MRI * Pregnancy * History of TIA within last 6 months. * Presently involved in open litigation

Design outcomes

Primary

MeasureTime frame
The main outcome variable in the study will be the change in Post-Concussion Symptom Scale (PCSS) score from the initial intake evaluation compared to last follow-up evaluation.Up to 6 months

Secondary

MeasureTime frame
Change in the Satisfaction with Life ScaleUp to 6 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026